Downstream Processing Industry News
- Omeros Announces Toxicology Data That Support Advancing MASP-2 Inhibitor Into Clinical Trials 3/28/2013
-
Biologics Research Promises To Bolster Future Of Medicine
3/11/2013
America's biopharmaceutical companies are using biological processes to develop 907 medicines and vaccines targeting more than 100 diseases, according to a new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA).
-
IGF-1 And Long IGF-1 LR3 Is There A Difference? US Peptides Discusses
2/11/2013
Research peptides are used around the world for a number of reason but most notably to test the effects of growth hormone related hormones and growth hormone related peptides and their effects.
-
Amgen Outlines Long-Term Strategy
2/7/2013
Amgen (NASDAQ: AMGN) today outlined the company's long-term strategy during a Business Review meeting with analysts and investors inNew York City.
-
Generex Provides An Overview Of Its Cancer Immunotherapy Product, AE37, And Potential In Early Breast Cancer Given Current And Potential Future Therapies
1/30/2013
Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today provided an overview on the early breast cancer competitive status of the lead cancer immunotherapy product, AE37, under development at its wholly-owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com).
-
DSM Announces License Agreement With Amgen For Use Of DSM's XD® Cell Culture Patents
1/15/2013
DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE, Euronext: DSM KON), announced today that it has signed a non-exclusive license agreement with Amgen Inc. for access to DSM's proprietary XD® high cell density process patents.
-
BioInvent Recruits New Chief Executive Officer
1/9/2013
BioInvent International AB recently announced that Svein Mathisen has resigned from his positions as chief executive officer of the Company and as member of the Board of Directors.
-
Star Scientific, Inc./Rock Creek Pharmaceuticals Report Positive Initial Results Of ASAP Human Thyroid Health Study Showing Benefits In Immune System Support
1/7/2013
Glen Allen, VA /PRNewswire/ - Star Scientific, Inc. (NASDAQ: STSI) announced today the preliminary results of the Company's ASAP (Anatabloc Supplementation Autoimmune Prevention) Human Thyroid Study that analyzes the impact of anatabine dietary supplementation on thyroid health.
-
Gradalis, Inc. Closes $24M In Series B Financing To Advance Late-Stage Trials Of FANG™ Personalized Cancer Vaccine
1/3/2013
Gradalis, Inc. today announced that is has closed a $24 million Series B round of financing. Gradalis will use the funding to advance its autologous vaccine platform, FANG™, through late-stage clinical trials and expand manufacturing capabilities to accommodate commercial launch of FANG.
-
ArmaGen Technologies, Inc. Hires Biotech Executive As CEO
1/3/2013
ArmaGen Technologies, Inc., a leader in the delivery of biotherapeutics targeting the central nervous system (CNS), today announced James Callaway , Ph.D. as Chief Executive Office and member of the Board of Directors.